| Issue | Title | |
| Vol 8, No 4 (2015) | PLANNING OF EXTENT AND FINANCIAL EXPENSES FOR DELIVERY OF HEALTH CARE IN HOSPITALS AT THE FEDERAL AND REGIONAL LEVELS | Abstract PDF (Rus) |
| M. V. Sura | ||
| Vol 18, No 2 (2025) | Population consumption of antihypertensive and lipid-lowering drugs in the Russian Federation (SPARDEC) | Abstract PDF (Rus) |
| Zh. D. Kobalava, I. K. Petrukhina, P. A. Lebedev, P. R. Blinkova, T. K. Ryazanova, E. P. Gladunova, E. V. Paranina | ||
| Vol 16, No 4 (2023) | Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis | Abstract PDF (Rus) |
| A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva | ||
| Vol 15, No 4 (2022) | Possibilities of physical therapy and electrophysical modalities in the complex therapy of pneumonia | Abstract PDF (Rus) |
| D. I. Korabelnikov, V. V. Grigoryev, О. V. Efimova | ||
| Vol 16, No 3 (2023) | Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation | Abstract PDF (Rus) |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov | ||
| Vol 11, No 1 (2018) | Presepsin as a sepsis biomarker | Abstract PDF (Rus) |
| K. A. Trunova | ||
| Vol 9, No 4 (2016) | PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY) | Abstract PDF (Rus) |
| D. Kh. Kalimullina, A. S. Yurkina, T. I. Ushakova, D. V. Blinov | ||
| Vol 12, No 1 (2019) | Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation | Abstract PDF (Rus) |
| T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko | ||
| Vol 17, No 2 (2024) | Primary prevention of venous thromboembolism with low molecular weight heparins in surgical patients – 2024: Council of Experts resolution | Abstract PDF (Rus) |
| А. S. Petrikov, Т. V. Vavilova, А. V. Vardanyan, М. N. Zamyatin, I. А. Zolotukhin, К. V. Lobastov, Е. V. Roitman, Е. I. Seliverstov, Yu. М. Stoyko, I. А. Suchkov | ||
| Vol 8, No 2 (2015) | PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS | Abstract PDF (Rus) |
| Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova | ||
| Vol 16, No 1 (2023) | Principles of medical care standards development based on clinical guidelines | Abstract PDF (Rus) |
| Yu. A. Ledovskikh, S. N. Tishkina, G. I. Pirova, E. V. Semakova, V. V. Omelyanovskiy | ||
| Vol 7, No 3 (2014) | PROBLEMS OF OUTCOMES CHOICE FOR THE ASSESSMENT OF REHABILITATION PROGRAMS EFFICIENCY IN PATIENTS AFTER STROKE AND CRANIOCEREBRAL INJURY | Abstract PDF (Rus) |
| V. S. Dombrovskiy, V. V. Omelyanovskiy | ||
| Vol 18, No 1 (2025) | Problems of using phenol (hydroxybenzene) and parabens as pharmaceutical stabilizers: analysis using machine learning methods | Abstract PDF (Rus) |
| I. Yu. Torshin, O. A. Gromova | ||
| Vol 13, No 2 (2020) | Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation | Abstract PDF (Rus) |
| S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva | ||
| Vol 9, No 4 (2016) | PROPOSALS AND RECOMMENDATIONS FOR OPTIMIZATION OF THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS | Abstract PDF (Rus) |
| D. V. Fedyaev, D. V. Lukyantseva, V. I. Ignatyeva | ||
| Vol 15, No 3 (2022) | Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) | Abstract PDF (Rus) |
| I. Yu. Torshin, О. A. Gromova, A. M. Lila | ||
| Vol 13, No 1 (2020) | Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system | Abstract PDF (Rus) |
| I. Yu. Torshin, A. М. Lila, O. A. Limanova, O. A. Gromova | ||
| Vol 9, No 1 (2016) | PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS | Abstract PDF (Rus) |
| N. Z. Musina, V. V. Tarasov | ||
| Vol 16, No 1 (2023) | Prospects for using high-throughput sequencing methods to identify new biomarkers of response and resistance to antitumor therapy | Abstract PDF (Rus) PDF (Rus) |
| M. А. Sorokina, T. R. Grishina | ||
| Vol 14, No 4 (2021) | Prospects of using chondroprotectors for the treatment of pulmonary pathology | Abstract PDF (Rus) |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin | ||
| Vol 17, No 4 (2024) | Proteomic analysis of synergetic neuroprotective effect of adenosine, thiamine, niacin and cyanocobalamin in pathophysiology of diabetic polyneuropathy | Abstract PDF (Rus) |
| O. A. Gromova, I. Yu. Torshin, A. G. Moiseenok | ||
| Vol 16, No 2 (2023) | Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice | Abstract PDF (Rus) |
| M. S. Soboleva | ||
| Vol 10, No 3 (2017) | Provision of free medical care in Russia and elsewhere: review of regulatory and legal aspects | Abstract PDF (Rus) |
| A. N. Daikhes, D. V. Fedyaev | ||
| Vol 5, No 3 (2012) | RATIONALE FOR THE SYSTEM OF INDICATORS, INTENDED FOR THE EVALUATION OF INVESTMENT EFFECTIVENESS IN THE FINANCING OF INVESTMENT PROJECTS IMPLEMENTED USING THE FUNDS OF THE POPULATION | Abstract PDF (Rus) |
| E. V. Litvinenko | ||
| Vol 13, No 1 (2020) | Real-time RT-PCR diagnostics of virus causing COVID-19 | Abstract PDF (Rus) |
| E. V. Goncharova, A. E. Donnikov, V. V. Kadochnikova, S. A. Morozova, M. N. Boldyreva, I. S. Galkina, D. V. Blinov | ||
| Vol 16, No 2 (2023) | Real-world data: principles of use in decision making and in health technology assessment | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva | ||
| Vol 8, No 2 (2015) | REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS | Abstract PDF (Rus) |
| Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev | ||
| Vol 12, No 2 (2019) | Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU | Abstract PDF (Rus) |
| G. N. Gildeeva, A. V. Belostotsky | ||
| Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract PDF (Rus) |
| M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
| Vol 13, No 4 (2020) | Regional aspects for assessing the effectiveness of resources management in medical organizations | Abstract PDF (Rus) |
| О. A. Volkova, E. V. Smirnova, S. N. Cherkasov | ||
| Vol 17, No 4 (2024) | Regional aspects of availability of expectorants and antitussive drugs | Abstract PDF (Rus) |
| V. М. Timiryanova, А. V. Samorodov, Z. А. Valiullina, V. B. Prudnikov, D. Kh. Krasnoselskaya | ||
| Vol 12, No 3 (2019) | Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia | Abstract PDF (Rus) |
| V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina | ||
| Vol 13, No 3 (2020) | Regulatory framework of the oncological medical care provision | Abstract PDF (Rus) |
| S. N. Tishkina, V. E. Matskevich, Yu. A. Ledovskikh, E. V. Semakova, V. V. Omelyanovskiy | ||
| Vol 18, No 1 (2025) | Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia | Abstract PDF (Rus) |
| A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova | ||
| Vol 8, No 3 (2015) | RESEARCH EXCELLENCE INDEX AS INSTRUMENT OF PERFORMANCE-ORIENTED BUDGETING | Abstract PDF (Rus) |
| O. V. Bogacheva, V. E. Grigorov | ||
| Vol 9, No 4 (2016) | RESOLUTIONS OF VII RUSSIAN CONGRESS OF PATIENTS | Abstract PDF (Rus) |
| Editorial article | ||
| Vol 9, No 4 (2016) | Resolutions of VII Russian Congress of Patients | Abstract |
| Editorial article | ||
| Vol 10, No 1 (2017) | RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION | Abstract PDF (Rus) |
| M. V. Sura | ||
| Vol 18, No 2 (2025) | Results of adaptation of tools for standardizing value-based outcomes: analysis of ICHOM Standard Sets | Abstract PDF (Rus) |
| I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, J. A. Agafonova, N. S. Giliazetdinova, I. A. Mikhailov | ||
| Vol 18, No 3 (2025) | Results of the survey of experts on the need to incorporate real-world evidence to the comprehensive drug assessment | Abstract PDF (Rus) |
| F. V. Gorkavenko, V. V. Omelyanovskiy | ||
| Vol 16, No 3 (2023) | Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia | Abstract PDF (Rus) |
| A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva | ||
| Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract PDF (Rus) |
| A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
| Vol 14, No 1 (2021) | Review of foreign experience in the implementation of eHealth | Abstract PDF (Rus) |
| P. V. Minaev, D. V. Fedyaev, Yu. V. Seryapina, T. V. Skomorokhova | ||
| Vol 9, No 1 (2016) | REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES | Abstract PDF (Rus) |
| K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| Vol 15, No 3 (2022) | Review of international practice of health care provider network planning | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, D. V. Lukyantseva, N. N. Sisigina | ||
| Vol 14, No 3 (2021) | Review of methods for planning the scope of medical care and financing of the healthcare system by the subjects of the Russian Federation | Abstract PDF (Rus) |
| S. A. Kovaleva, D. V. Fedyaev, N. N. Sisigina | ||
| Vol 17, No 3 (2024) | Review of open libraries for pharmacoeconomic analysis in R environment | Abstract PDF (Rus) |
| I. A. Lackman, R. I. Sladkov, V. M. Timiryanova | ||
| Vol 9, No 4 (2016) | REVIEW OF PRACTICE AND POSSIBLE DIRECTIONS OF CONCRETIZATION THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS | Abstract PDF (Rus) |
| D. V. Fedyaev, L. S. Melnikova, V. I. Ignatyeva | ||
| Vol 10, No 3 (2017) | Review of the current approaches to the assessment of the drug innovative potential worldwide | Abstract PDF (Rus) |
| N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits | ||
| Vol 8, No 2 (2015) | REVIEW OF THE INTERNATIONAL PRACTICE OF COST-SHARING MECHANISM IN NATIONAL HEALTH CARE SYSTEMS | Abstract PDF (Rus) |
| Natalia Nikolayevna Sisigina, Vitalii Vladimirovich Omel'yanovskii, Nikolay Alexandrovich Avxentyev | ||
| 401 - 450 of 539 Items | << < 4 5 6 7 8 9 10 11 > >> | |
Browse Title Index
Popular articles
Vol 10, No 1 (2017)
Vol 17, No 3 (2024)
Vol 16, No 3 (2023)
Vol 16, No 4 (2023)
Vol 13, No 1 (2020)
Vol 14, No 4 (2021)
Keywords
COVID-19
artificial intelligence
budget impact analysis
chemotherapy
children
chondroitin sulfate
clinical and economic analysis
cost minimization analysis
cost-effectiveness analysis
cost-utility analysis
drug supply
drugs
glucosamine sulfate
health technology assessment
oncology
pharmaceutical market
pharmacoeconomic analysis
pharmacoeconomics
pharmacoepidemiology
pharmacoinformatics
quality of life
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
